Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Left Atrial Appendage Closure Device Market from 2024 to 2025?
In recent times, there has been a significant expansion in the market size of left atrial appendage closure devices. The market, which stood at $1.67 billion in 2024, is projected to reach $2 billion in 2025, representing a compound annual growth rate (CAGR) of 19.5%. Factors such as an increase in atrial fibrillation incidents, the adoption of stroke prevention tactics, the emergence of clinical studies and research, the introduction of minimally invasive alternatives, patient inclination towards non-drug solutions, an aging population, and advancements in physician training and skills have all contributed to this historic growth period.
What Is the Projected Market Size of the Left Atrial Appendage Closure Device Market?
Predictions indicate that the left atrial appendage closure device market is set to experience notable expansion in the coming years. It is anticipated to reach a worth of $3.74 billion in 2029, achieving a compound annual growth rate (CAGR) of 17.0%. The projected growth in the mentioned period can be ascribed to the increasing worldwide incidence of atrial fibrillation, emphasis on preventing strokes in patients at high risk, enhanced patient awareness, its amalgamation into routine clinical practices, and global initiatives in managing cardiovascular diseases. The upcoming period is likely to witness key trends including the emerging percutaneous closure methods, improvements in device designs, growing utilization of imaging technologies, inclination towards minimally invasive procedures, and custom device selection based on patient’s anatomy.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13474&type=smp
Who are the Major Competitors in the Left Atrial Appendage Closure Device Market Outlook?
Major companies operating in the left atrial appendage closure device market report are Johnson And Johnson Pvt Ltd., Abbott Laboratories, Medtronic plc., Atrium Medical Corporation, Boston Scientific Corporation, Gore Medical Inc., Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, AtriCure Inc., Dune Medical Devices Ltd., Lifetech Scientific Corporation, Sahajanand Medical Technologies Limited, Occlutech, Cardiva Medical Inc., Sentreheart Inc., Aegis Medical Group, Coherex Medical Inc., EndoStim Inc., Conformal Medical Inc., Cardia Inc., Medical Device Business Service Inc., Protaryx Medical, Append Medical Ltd., Vascular Innovations Co. Ltd., Vivasure Medical Inc., Atritech Inc., CardiaMed AB, Cardialen Inc., Kalila Medical Inc.
What Is Fueling Growth in the Left Atrial Appendage Closure Device Market?
Expectations of a surge in atrial fibrillation occurrences are anticipated to stimulate advancements within the left atrial appendage (LAA) closure device market. Atrial fibrillation, recognized as an irregular and unusually rapid heart rhythm, is caused by the heart’s upper chambers, the atria, failing to beat consistently and rhythmically. To manage this health condition, left atrial appendage (LAA) closure devices are largely used. Their function is to lower the potential for strokes in patients with this type of cardiac arrhythmia and to prevent formation or escape of blood clots. For instance, reports from the Centers for Disease Control and Prevention in October 2022 state atrial fibrillation as the primary diagnosis for over 454,000 hospital admissions annually in the US. By 2030, the estimate is that the US will have 12.1 million people with atrial fibrillation. Consequently, the left atrial appendage (LAA) closure device market is predicted to grow in response to the increased rate of atrial fibrillation.
Left Atrial Appendage Closure Device Market Driver: Elderly Demographic Propels Expansion In Left Atrial Appendage Closure Device Market
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=13474&type=smp
Which Left Atrial Appendage Closure Device Market Segments Are Growing the Fastest?
The left atrial appendage closure device market covered in this report is segmented –
1) By Product: Epicardial Left Atrial Appendage (LAA) Devices, Endocardial Left Atrial Appendage (LAA) Devices
2) By Procedure: Percutaneous, Surgical
3) By End-User: Hospital, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Epicardial Left Atrial Appendage (LAA) Devices: Suture-Based Closure Devices, Ligation-Based Closure Devices, Clip-Based Closure Devices
2) By Endocardial Left Atrial Appendage (LAA) Devices: Plug-Based Closure Devices, Disc-Based Closure Devices, Mesh-Based Closure Devices
Which Industry Trends Are Shaping the Future of the Left Atrial Appendage Closure Device Market?
The main firms in the left atrial appendage closure device market are creating innovative developments such as the Watchman FLX, aimed at improving non-valvular atrial fibrillation (NVAF) treatment and offering patients an alternative to oral anticoagulation therapy. The Watchman FLX pro device is a self-expansive product implanted in the LAA to seal the opening and inhibit blood clot formation. For example, in September 2022, the US federal agency, the Food and Drug Administration, gave approval to the US-manufacturing company, Boston Scientific Corporation, for the use of Watchman FLX to decrease stroke risk among NVAF sufferers. The device’s flexibility and ease of implant make it a more feasible choice for a diverse set of patients than its predecessors. In addition, it’s a secure and successful method to limit NVAF-caused stroke threats, and it’s an advantageous choice for those not suitable for oral anticoagulation therapy or struggle to manage their oral anticoagulation treatment.
Access The Full Report Here:
Which Countries Are Leading the Left Atrial Appendage Closure Device Market?
North America was the largest region in the left atrial appendage closure devices market in 2024. The regions covered in the left atrial appendage closure device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13474
This Report Delivers Insight On:
1. How big is the left atrial appendage closure device market, and how is it changing globally?
2. Who are the major companies in the left atrial appendage closure device market, and how are they performing?
3. What are the key opportunities and risks in the left atrial appendage closure device market right now?
4. Which products or customer segments are growing the most in the left atrial appendage closure device market?
5. What factors are helping or slowing down the growth of the left atrial appendage closure device market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
